Enhancing cell‐based therapies with synthetic gene circuits responsive to molecular stimuli
Biotechnology and Bioengineering · 2024
DOI: 10.1002/bit.28770 ↗At a glance
Übersichtsarbeit in Biotechnology and Bioengineering, 2024. Written by Silvia Galvan and 2 co-authors. Institution: Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland. Major MEDLINE topics: Cell- and Tissue-Based Therapy, Synthetic Biology, Gene Regulatory Networks. Cited 16 times so far (Crossref); 122 references. The full text is freely available (open access, CC BY 4.0). Funded by: European Research Council.
Abstract (original language)
Synthetic biology aims to contribute to the development of next‐generation patient‐specific cell‐based therapies for chronic diseases especially through the construction of sophisticated synthetic gene switches to enhance the safety and spatiotemporal controllability of engineered cells. Indeed, switches that sense and process specific cues, which may be either externally administered triggers or endogenous disease‐associated molecules, have emerged as powerful tools for programming and fine‐tuning therapeutic outputs. Living engineered cells, often referred to as designer cells, incorporating such switches are delivered to patients either as encapsulated cell implants or by infusion, as in the case of the clinically approved CAR‐T cell therapies. Here, we review recent developments in synthetic gene switches responsive to molecular stimuli, spanning regulatory mechanisms acting at the transcriptional, translational, and posttranslational levels. We also discuss current challenges facing clinical translation of cell‐based therapies employing these devices.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
- Faculty of Science, University of Basel, Basel, Switzerland.
Funding
- European Research Council
Cite
APA
Galvan, S., Teixeira, A. P., & Fussenegger, M. (2024). Enhancing cell‐based therapies with synthetic gene circuits responsive to molecular stimuli. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28770
Vancouver
Galvan S, Teixeira AP, Fussenegger M. Enhancing cell‐based therapies with synthetic gene circuits responsive to molecular stimuli. Biotechnology and Bioengineering. 2024. doi:10.1002/bit.28770
BibTeX
@article{Galvan2024,
author = {Galvan, Silvia and Teixeira, Ana P and Fussenegger, Martin},
title = {Enhancing cell‐based therapies with synthetic gene circuits responsive to molecular stimuli},
journal = {Biotechnology and Bioengineering},
year = {2024},
doi = {10.1002/bit.28770}
}
EUVIMED